# DEFB4B

## Overview
DEFB4B is a gene that encodes the protein defensin beta 4B, a member of the beta-defensin family of antimicrobial peptides. These peptides are integral to the innate immune system, providing a primary defense mechanism against a variety of pathogens, including bacteria, fungi, and viruses. Defensin beta 4B is predominantly expressed in epithelial tissues, where it plays a critical role in maintaining barrier integrity by disrupting microbial membranes, thus preventing infections (Borchers2021Human). Beyond its antimicrobial activity, defensin beta 4B also exhibits immunomodulatory functions, acting as a cytokine that bridges innate and adaptive immunity, thereby enhancing the body's overall immune response (Hollox2003Extensive). Genetic polymorphisms in DEFB4B can lead to variations in expression levels, influencing susceptibility to immune-related conditions such as asthma, allergies, and inflammatory diseases, underscoring its importance in immune regulation and disease prevention (Borchers2021Human).

## Function
DEFB4B encodes the protein defensin beta 4B, which is part of the beta-defensin family of antimicrobial peptides. These peptides play a crucial role in the innate immune system by providing a first line of defense against a wide range of pathogens, including bacteria, fungi, and viruses. Defensin beta 4B is primarily active in epithelial tissues, where it contributes to barrier protection by disrupting microbial membranes, thereby preventing infection (Borchers2021Human).

In addition to its antimicrobial properties, defensin beta 4B has immunomodulatory functions. It is involved in regulating immune responses, acting as a cytokine that links innate and adaptive immunity. This dual role enhances the body's ability to respond to infections effectively (Hollox2003Extensive). The protein's activity is not limited to direct antimicrobial action; it also influences the expression of other immune-related genes, potentially affecting the overall immune response (Borchers2021Human).

The gene's expression levels can vary due to genetic polymorphisms, which may impact its function and influence susceptibility to conditions such as asthma and allergies (Borchers2021Human). These variations highlight the importance of DEFB4B in maintaining immune homeostasis and its potential role in disease prevention.

## Clinical Significance
Mutations and alterations in the expression of the DEFB4B gene have been associated with several inflammatory and immune-related conditions. In children, mutations in DEFB4B are linked to an increased risk of asthma and atopy. The study suggests that these genetic variations may influence the regulation of human β-defensin 2 (hBD-2), potentially affecting susceptibility to these conditions (Borchers2021Human). 

In the context of Crohn's disease, particularly affecting the colon, a lower copy number of the DEFB4B gene has been associated with an increased risk. This reduced gene copy number correlates with diminished expression of hBD-2, which may contribute to the chronic inflammation characteristic of Crohn's disease (Fellermann2006A). 

Conversely, an increased copy number of DEFB4B has been linked to a higher risk of psoriasis, a common inflammatory skin disease. This suggests that the gene's copy number variations can influence the susceptibility to psoriasis, potentially due to its role in the innate immune response and skin barrier function (Hollox2007Psoriasis). 

These findings highlight the clinical significance of DEFB4B in various inflammatory and immune-mediated diseases.


## References


[1. (Hollox2007Psoriasis) Edward J Hollox, Ulrike Huffmeier, Patrick L J M Zeeuwen, Raquel Palla, Jesús Lascorz, Diana Rodijk-Olthuis, Peter C M van de Kerkhof, Heiko Traupe, Gys de Jongh, Martin den Heijer, André Reis, John A L Armour, and Joost Schalkwijk. Psoriasis is associated with increased β-defensin genomic copy number. Nature Genetics, 40(1):23–25, December 2007. URL: http://dx.doi.org/10.1038/ng.2007.48, doi:10.1038/ng.2007.48. This article has 507 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.2007.48)

[2. (Hollox2003Extensive) E.J. Hollox, J.A.L. Armour, and J.C.K. Barber. Extensive normal copy number variation of a β-defensin antimicrobial-gene cluster. The American Journal of Human Genetics, 73(3):591–600, September 2003. URL: http://dx.doi.org/10.1086/378157, doi:10.1086/378157. This article has 249 citations.](https://doi.org/10.1086/378157)

[3. (Fellermann2006A) Klaus Fellermann, Daniel E. Stange, Elke Schaeffeler, Hartmut Schmalzl, Jan Wehkamp, Charles L. Bevins, Walter Reinisch, Alexander Teml, Matthias Schwab, Peter Lichter, Bernhard Radlwimmer, and Eduard F. Stange. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to crohn disease of the colon. The American Journal of Human Genetics, 79(3):439–448, September 2006. URL: http://dx.doi.org/10.1086/505915, doi:10.1086/505915. This article has 392 citations.](https://doi.org/10.1086/505915)

[4. (Borchers2021Human) Natascha S. Borchers, Elisangela Santos-Valente, Antoaneta A. Toncheva, Jan Wehkamp, Andre Franke, Vincent D. Gaertner, Peter Nordkild, Jon Genuneit, Benjamin A. H. Jensen, and Michael Kabesch. Human β-defensin 2 mutations are associated with asthma and atopy in children and its application prevents atopic asthma in a mouse model. Frontiers in Immunology, February 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.636061, doi:10.3389/fimmu.2021.636061. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.636061)